Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Latest Advisory Opinion Has Double Trouble for Laboratories
By Christopher P. Young, Editor, G2 Compliance Advisor A long standing issue in the laboratory industry is once again under scrutiny as the result of a U.S. Department of Health and Human Services' Office of Inspector General (OIG) Advisory Opinion (AO 15-04)...
BCBS, U of Michigan Partner to Optimize Molecular Test Utilization
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Blue Cross Blue Shield (BCBS) of Michigan and the University of Michigan Health System are collaborating with physicians and laboratories across the state to improve molecular testing...
Agena Bioscience Launches Testing Platform For Non-Small Cell Lung Cancer
By Ron Shinkman, Editor, Laboratory Industry Report San Diego-based Agena Biosciences has released a new testing platform that provides a quick and accurate identification of variations in most non-small cell lung cancers. The platform, known as the LungFusion...
AMP Weighs In on Regulation of Next-Generation Sequencing
By Stephanie Murg, Managing Director, G2 Intelligence As the U.S. Food and Drug Administration (FDA) evaluates its role in regulating next-generation sequencing (NGS)-based diagnostic tests, a range of stakeholders have responded to the agency's request for...